结核病患者的结局根据病情严重程度在呈现时
S V Leavitt1, C A Rodriguez2, T C Bouton3
1Departments of Biostatistics and.
概括
结核病 (TB) 疾病在呈现时的严重程度显著影响结果. 最小结核病的5年死亡率为2%,而晚期结核病的死亡率为40%,这凸显了根据严重程度进行治疗的必要性.
科学领域:
- 医学研究 医学研究
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 结核病 (TB) 疾病表现呈现出显著的异质性.
- 呈现时的疾病严重程度可能与患者的结果相关.
- 从化疗前的历史数据被用来了解结核病的进展.
研究的目的:
- 根据结核病患者表现时的疾病严重程度来估计疾病结果.
- 根据结核病的严重程度分层分析生存分布和自然恢复几率.
- 提供有关放射学发现对结核病预后的影响的见解.
主要方法:
- 从1917年至1948年在美国招募的结核病患者提取数据.
- 根据美国国家结核病协会的标准,将患者分为"最小"",中度发达"和"非常发达"的疾病严重程度类别.
- 应用贝叶斯参数生存分析和后勤回归到模型生存和恢复.
主要成果:
- 患有最小结核病的个体在5年内死亡的概率为2%,而患有晚期结核病的人则为40%.
- 最小结核病患者在3年内自然康复的几率是远远晚期结核病患者的13.62倍.
- 在疾病严重程度水平上观察到死亡率和自然恢复率的显著变化.
结论:
- 呈现时的疾病严重程度是结核病死亡率和自然恢复的关键决定因素.
- 对结核病严重程度的放射性评估对于预测结核病结果是有价值的.
- 这些发现支持开发针对疾病严重程度量身定制的个性化治疗方案.
相关概念视频
Pulmonary Tuberculosis III
325
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
325
Pulmonary Tuberculosis IV
142
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
142
Pulmonary Tuberculosis V
179
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
179
Pulmonary Tuberculosis I
242
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
242
Pulmonary Tuberculosis II
236
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
236
Pneumonia IV: Management
324
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
324


